The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
The rapid emergence of antimicrobial resistance (AMR) poses a critical threat to global health, demanding innovative research strategies beyond conventional ...
Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the 'Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today ...
Researchers developed PerturbFate, a tool that tracks how genetic mutations reshape cells and identifies shared regulatory ...